AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesDisciplines and OccupationsHealth Care
AconitineAconitumInfusions, IntravenousInfusions, ParenteralCladribineDrug EvaluationDrug Administration ScheduleInfusion PumpsGuaifenesinDiabetic ComaInjections, IntravenousDose-Response Relationship, DrugVeratridineSodium Channel AgonistsFluorouracilDioxolesInjections, SubcutaneousNeoplasmsArrhythmias, CardiacTreatment OutcomeHemodynamicsTime FactorsLeucineDogsBlood PressureAntineoplastic Combined Chemotherapy ProtocolsMetabolic Clearance RateBatrachotoxinsNeutropeniaAlkaloidsCarbon IsotopesMaximum Tolerated DoseOligonucleotides, AntisenseRecombinant ProteinsHeart RateArea Under CurveVentromedial Hypothalamic NucleusPharmacologyCytarabineThrombocytopeniaAntineoplastic AgentsRandom AllocationRats, Sprague-DawleyRemission InductionDouble-Blind MethodAnti-Arrhythmia AgentsBlood GlucoseCisplatinInfusions, Intra-ArterialTetrodotoxinInterleukin-2RabbitsHeparinSurvival AnalysisRats, Inbred StrainsDrugs, Chinese HerbalCombined Modality Therapy
Drug
Drug1
  • Arrhythmogenesis was assessed 24 hr later by continuous intravenous infusion of aconitine, an arrhythmogenic drug, while heart rate (HR) and electrocardiogram (ECG) were monitored. (nih.gov)